Risk factors for early revision after total hip arthroplasty

Arthritis Care and Research

Volumn 66, Issue 6, 2014, Pages 907-915

  Dy, Christopher J ^a   Bozic, Kevin J ^b   Pan, Ting Jung ^a   Wright, Timothy M ^a   Padgett, Douglas E ^a   Lyman, Stephen ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; POSTOPERATIVE INFECTION; REOPERATION; RISK FACTOR; TOTAL HIP PROSTHESIS;

AGE FACTORS; AGED; ARTHROPLASTY, REPLACEMENT, HIP; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; REOPERATION; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84901654874     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22240     Document Type: Article

References (49)

1. Kurtz S, Ong K, Lau E, Mowat F, Halpern M,. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89: 780-5.
2. Kurtz SM, Ong KL, Schmier J, Mowat F, Saleh K, Dybvik E, et al. Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am 2007; 89 Suppl 3: 144-51.
3. Dorr LD, Takei GK, Conaty JP,. Total hip arthroplasties in patients less than forty-five years old. J Bone Joint Surg Am 1983; 65: 474-9.
4. Broos P, Fourneau I,. Host factors that affect outcome of total hip arthroplasty. Lancet 2000; 29: 1479-80.
5. Lansky D, Nwachukwu BU, Bozic KJ,. Using financial incentives to improve value in orthopaedics. Clin Orthop Relat Res 2012; 470: 1027-37.
6. Kurtz S, Mowat F, Ong K, Chan N, Lau E, Halpern M,. Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. J Bone Joint Surg Am 2005; 87: 1487-97.
7. Clohisy JC, Calvert G, Tull F, McDonald D, Maloney WJ,. Reasons for revision hip surgery: a retrospective review. Clin Orthop Relat Res 2004; 429: 188-92.
8. Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ,. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am 2009; 91: 128-33.
9. Dobzyniak M, Fehring TK, Odum S,. Early failure in total hip arthroplasty. Clin Orthop Relat Res 2006; 447: 76-8.
10. Allen BR, Rosenzweig S, Myers L, Barrack RL,. The Frank Stinchfield Award: the impact of socioeconomic factors on outcome after THA. A prospective, randomized study. Clin Orthop Relat Res 2011; 469: 339-47.
11. Santaguida PL, Hawker GA, Hudak PL, Glazier R, Mahomed NN, Kreder HJ, et al. Patient characteristics affecting the prognosis of total hip and knee joint arthroplasty: a systematic review. Can J Surg 2008; 51: 428-36.
12. Bozic KJ, Lau E, Ong K, Chan V, Kurtz S, Vail TP, et al. Risk factors for early revision after primary total hip arthroplasty in Medicare patients. Clin Orthop Relat Res 2014; 472: 449-54.
13. Inacio MC, Ake CF, Paxton EW, Khatod M, Wang C, Gross TP, et al. Sex and risk of hip implant failure: assessing total hip arthroplasty outcomes in the United States. JAMA Intern Med 2013; 173: 435-41.
14. Heck DA, Melfi CA, Mamlin LA, Katz BP, Arthur DS, Dittus RS, et al. Revision rates after knee replacement in the United States. Med Care 1998; 36: 661-9.
15. Archibeck MJ, Berger RA, Jacobs JJ, Quigley LR, Gitelis S, Rosenberg AG, et al. Second-generation cementless total hip arthroplasty: eight to eleven-year results. J Bone Joint Surg Am 2001; 83A: 1666-73.
16. Engh CA Jr, Culpepper WJ II, Engh CA,. Long-term results of use of the anatomic medullary locking prosthesis in total hip arthroplasty. J Bone Joint Surg Am 1997; 79: 177-84.
17. Clohisy JC, Harris WH,. The Harris-Galante porous-coated acetabular component with screw fixation: an average ten-year follow-up study. J Bone Joint Surg Am 1999; 81: 66-73.
18. Milosev I, Kovac S, Trebse R, Levasic V, Pisot V,. Comparison of ten-year survivorship of hip prostheses with use of conventional polyethylene, metal-on-metal, or ceramic-on-ceramic bearings. J Bone Joint Surg Am 2012; 94: 1756-63.
19. Havelin LI, Engesaeter LB, Espehaug B, Furnes O, Lie SA, Vollset SE,. The Norwegian Arthroplasty Register: 11 years and 73,000 arthroplasties. Acta Orthop Scand 2000; 71: 337-53.
20. Hooper GJ, Rothwell AG, Stringer M, Frampton C,. Revision following cemented and uncemented primary total hip replacement: a seven-year analysis from the New Zealand Joint Registry. J Bone Joint Surg Br 2009; 91: 451-8.
21. Katz JN, Wright EA, Baron JA, Corbett KL, Nti AA, Malchau H, et al. Predictive value of Medicare claims data for identifying revision of index hip replacement was modest. J Clin Epidemiol 2011; 64: 543-6.
22. Elixhauser A, Steiner C, Harris DR, Coffey RM,. Comorbidity measures for use with administrative data. Med Care 1998; 36: 8-27.
23. Rural-Urban Commuting Area Codes. 2013. URL: http://depts.washington.edu/ uwruca/index.php.
24. Sporer SM,. How to do a revision total hip arthroplasty: revision of the acetabulum. Instr Course Lect 2012; 61: 303-11.
25. Deirmengian GK, Zmistowski B, O'Neil JT, Hozack WJ,. Management of acetabular bone loss in revision total hip arthroplasty. J Bone Joint Surg Am 2011; 93: 1842-52.
26. Hartman CW, Garvin KL,. Femoral fixation in revision total hip arthroplasty. J Bone Joint Surg Am 2011; 93: 2311-22.
27. Bozic KJ, Katz P, Cisternas M, Ono L, Ries MD, Showstack J,. Hospital resource utilization for primary and revision total hip arthroplasty. J Bone Joint Surg Am 2005; 87: 570-6.
28. Ong KL, Lau E, Suggs J, Kurtz SM, Manley MT,. Risk of subsequent revision after primary and revision total joint arthroplasty. Clin Orthop Relat Res 2010; 468: 3070-6.
29. Patil S, Garbuz DS, Greidanus NV, Masri BA, Duncan CP,. Quality of life outcomes in revision vs primary total hip arthroplasty: a prospective cohort study. J Arthroplasty 2008; 23: 550-3.
30. Lubbeke A, Katz JN, Perneger TV, Hoffmeyer P,. Primary and revision hip arthroplasty: 5-year outcomes and influence of age and comorbidity. J Rheumatol 2007; 34: 394-400.
31. Fender D, van der Meulen JH, Gregg PJ,. Relationship between outcome and annual surgical experience for the charnley total hip replacement: results from a regional hip register. J Bone Joint Surg Br 2003; 85: 187-90.
32. Katz JN, Losina E, Barrett J, Phillips CB, Mahomed NN, L, ew RA, et al. Association between hospital and surgeon procedure volume and outcomes of total hip replacement in the United States medicare population. J Bone Joint Surg Am 2001; 83A: 1622-9.
33. Shervin N, Rubash HE, Katz JN,. Orthopaedic procedure volume and patient outcomes: a systematic literature review. Clin Orthop Relat Res 2007; 457: 35-41.
34. Havelin LI, Espehaug B, Vollset SE, Engesaeter LB,. Early failures among 14,009 cemented and 1,326 uncemented prostheses for primary coxarthrosis: the Norwegian Arthroplasty Register, 1987-1992. Acta Orthop Scand 1994; 65: 1-6.
35. Malchau H, Herberts P, Eisler T, Garellick G, Soderman P,. The Swedish Total Hip Replacement Register. J Bone Joint Surg Am 2002; 84-A Suppl 2: 2-20.
36. Prokopetz JJ, Losina E, Bliss RL, Wright J, Baron JA, Katz JN,. Risk factors for revision of primary total hip arthroplasty: a systematic review. BMC Musculoskelet Disord 2012; 13: 251.
37. Agabiti N, Picciotto S, Cesaroni G, Bisanti L, Forastiere F, Onorati R, et al. The influence of socioeconomic status on utilization and outcomes of elective total hip replacement: a multicity population-based longitudinal study. Int J Qual Health Care 2007; 19: 37-44.
38. Hinman A, Bozic KJ,. Impact of payer type on resource utilization, outcomes and access to care in total hip arthroplasty. J Arthroplasty 2008; 23 Suppl 1: 9-14.
39. Martin CT, Callaghan JJ, Liu SS, Gao Y, Warth LC, Johnston RC,. Disparity in total joint arthroplasty patient comorbidities, demographics, and postoperative outcomes based on insurance payer type. J Arthroplasty 2012; 27: 1761-5.
40. Warth LC, Callaghan JJ, Wells CW, Liu SS, Klaassen A, Gao Y, et al. Demographic and comorbid disparities based on payer type in a total joint arthroplasty cohort: implications in a changing health care arena. Iowa Orthop J 2011; 31: 64-8.
41. Furnes O, Lie SA, Espehaug B, Vollset SE, Engesaeter LB, Havelin LI,. Hip disease and the prognosis of total hip replacements: a review of 53,698 primary total hip replacements reported to the Norwegian Arthroplasty Register 1987-99. J Bone Joint Surg Br 2001; 83: 579-86.
42. Schrama JC, Espehaug B, Hallan G, Engesaeter LB, Furnes O, Havelin LI, et al. Risk of revision for infection in primary total hip and knee arthroplasty in patients with rheumatoid arthritis compared with osteoarthritis: a prospective, population-based study on 108,786 hip and knee joint arthroplasties from the Norwegian Arthroplasty Register. Arthritis Care Res (Hoboken) 2010; 62: 473-9.
43. Lenchik L, Sartoris DJ,. Orthopedic aspects of metabolic bone disease. Orthop Clin North Am 1998; 29: 103-34.
44. Kobayashi S, Saito N, Horiuchi H, Iorio R, Takaoka K,. Poor bone quality or hip structure as risk factors affecting survival of total-hip arthroplasty. Lancet 2000; 355: 1499-504.
45. Rolfson O, Dahlberg LE, Nilsson JA, Malchau H, Garellick G,. Variables determining outcome in total hip replacement surgery. J Bone Joint Surg Br 2009; 91: 157-61.
46. Soohoo NF, Farng E, Lieberman JR, Chambers L, Zingmond DS,. Factors that predict short-term complication rates after total hip arthroplasty. Clin Orthop Relat Res 2010; 468: 2363-71.
47. Lavernia CJ, Contreras JS, Alcerro JC,. Access to arthroplasty in South Florida. J Arthroplasty 2012; 27: 1585-8.
48. Curtin B, Malkani A, Lau E, Kurtz S, Ong K,. Revision after total knee arthroplasty and unicompartmental knee arthroplasty in the medicare population. J Arthroplasty 2012; 27: 1480-6.
49. Khatod M, Inacio M, Paxton EW, Bini SA, Namba RS, Burchette RJ, et al. Knee replacement: epidemiology, outcomes, and trends in Southern California: 17,080 replacements from 1995 through 2004. Acta Orthop 2008; 79: 812-9. and Skin Diseases Musculoskeletal and Skin Diseases